🔎 Trials Near Me

Home › Atherosclerosis › Kansas

Atherosclerosis clinical trials in Kansas

5 studies for Atherosclerosis are looking for participants at sites in Kansas.

Cities in Kansas

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Cotton O'Neil Clinical Research Center, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • Midwest Heart & Vascular Specialists, LLC, Overland Park
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Cotton-ONeil Diabetes and Endocrinology Center, Topeka
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Kansas Nephrology Physicians, PA, Wichita
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.